B
BNR
Burning Rock Biotech Ltd
22.50
+1.94+9.44%After Hours: 22.50 0.00 0.00%16:10 04/16 EDT
OPEN/PREV CLOSE19.13/20.56
TODAY RANGE19.13-22.50
VOL35.95K
MARKET CAP242.25M
52 WEEK RANGE2.180-41.72
AVG VOL (3M)26.03K
% TURNOVER0.33%
TURNOVER--
P/E (TTM)-30.6623
% RANGE16.42%
EPS(TTM)-0.7338
P/E(FORWARD)-2.0698
P/B3.163
BVPS7.11
DIVIDEND--
P/S3.138
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP152.82M
SHARES OUTSTANDING10.77M
NEXT EARNINGS--
FREE FLOAT6.79M
LOT SIZE1
EX-DATE05/15/2024
News
Press Releases
Financial Reports
Profile
TipRanks·04/03 02:05
Insider Makes Bold Multi-Million Dollar Bet on Burning Rock Biotech
Reuters·04/02 11:18
Burning Rock director Han Yusheng buys USD 5.5 million in common shares
TipRanks·04/02 10:44
Burning Rock Biotech founder and CEO purchases company ADSs
Reuters·04/02 10:26
Burning Rock founder Han buys ADSs worth US$1.4 million
Barchart·04/02 05:25
Burning Rock Announces Founder’s Purchase of Its ADSs
Benzinga·03/13 17:06
12 Health Care Stocks Moving In Friday's Intraday Session
Seeking Alpha·03/12 19:45
Burning Rock Biotech GAAP EPS of -$0.02, revenue of $18.1M
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.